| 000 | 01740 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517020714.0 | ||
| 264 | 0 | _c20160308 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2015.02.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiñán-Rico, A | |
| 245 | 0 | 0 |
_aNeuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cAug 2015 |
||
| 300 |
_a83-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aColectomy |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPurinergic Agents _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Purinergic _xmetabolism |
| 650 | 0 | 4 |
_aSubmucous Plexus _xdrug effects |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 650 | 0 | 4 | _aVoltage-Sensitive Dye Imaging |
| 700 | 1 | _aWunderlich, J E | |
| 700 | 1 | _aEnneking, J T | |
| 700 | 1 | _aTso, D R | |
| 700 | 1 | _aGrants, I | |
| 700 | 1 | _aWilliams, K C | |
| 700 | 1 | _aOtey, A | |
| 700 | 1 | _aMichel, K | |
| 700 | 1 | _aSchemann, M | |
| 700 | 1 | _aNeedleman, B | |
| 700 | 1 | _aHarzman, A | |
| 700 | 1 | _aChristofi, F L | |
| 773 | 0 |
_tNeuropharmacology _gvol. 95 _gp. 83-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2015.02.014 _zAvailable from publisher's website |
| 999 |
_c24662410 _d24662410 |
||